It was a year in health news that will be hard to forget. As blockbuster weight-loss drugs known as GLP-1s made a sizable ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Astellas Pharma US, Inc. has issued a recall for one lot of PROGRAF 0.5mg (tacrolimus) and one lot of ASTAGRAF XL 0.5mg (tacrolimus extended-release) capsules ... via a drug recall notification ...

Ibudilast is under clinical development by MediciNova and currently in Phase II for Chemotherapy Induced Peripheral Neuropathy.

Risperidone ER is under clinical development by Lyndra Therapeutics and currently in Phase III for Schizophrenia.

A recent study suggests that taking a vitamin D supplement could lower your risk for dementia as you age, especially for ...

A Georgia bill regulating Kratom, aimed at preventing overdose deaths and other medical issues, takes effect Wednesday.

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

Matthew Kavanagh, the director of Georgetown University's Centre for Global Health Policy & Politics and an advisor to the United Nations explains on the progress and challenges in the ...

Losing weight in the new year won't take the same shape as it did in the past. Why it matters: The emergence of ...

While a stuffy nose is a common side effect of oral ED medications, switching from Cialis to shorter-lasting options like ...

Mount Sinai researchers discovered that harmine, a beta cell regenerative drug, may transform alpha cells into beta cells, ...